Compound versions of some weight loss drugs to be restricted
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...
Novo Nordisk stock slides Monday on second-generation GLP-1 data
Novo Nordisk stock was down more than 8% Monday morning after the Danish drugmaker shared new data on its next-generation GLP ...
The weight loss drug shortage is over — and some patients are 'panicking'
For Maria Rising, managing her health felt like chasing a phantom. The 30-year-old Lansing, Mich. consultant has for years ...
Novo Nordisk launches $499 Wegovy cash option and home delivery
Novo Nordisk announced a new cash-pay option for its blockbuster weight-loss drug Wegovy, offering a monthly dose at $499 and ...
The Scientific Search for Youth
Some early evidence also suggests GLP-1-based weight-loss drugs such as Wegovy, Ozempic, Mounjaro, and Zepbound might also ...
12:30 Report — Trump’s first economic report card
REPORT Happy Friday! This weekend is daylight saving time, I’d tell you to change your clocks but I’m guessing most of us ...
Novo Nordisk's Ozempic successor disappointed Wall Street again
Novo Nordisk (NVO) released clinical trial results for its potential Ozempic successor on Monday, disappointing Wall Street ...
S&P 500 closes higher on soft inflation report, Nasdaq jumps 1% as traders snap up tech shares
Uncertainty around President Donald Trump’s tariff policies have sent the major averages on a roller-coaster ride and spurred ...